Vulnerability · CVE-2026-32117
The grafanacubism-panel plugin allows use of cubism.js in Grafana.
Published Mar 11, 2026 · catalog updated Jun 17, 2026 · The grafanacubism-panel plugin allows
Check if you run it
No confirmed exploitation is on record for CVE-2026-32117. EPSS is 0.27%. Act only if a listed version of The grafanacubism-panel plugin allows is installed.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (The grafanacubism-panel plugin allows).
- No vendor fix or required action is stored. Compare the linked advisory before you change production.
- Severity
- Medium5.4
- Known exploitation
- Not in CISA/VulnCheck KEV
- EPSS
- 0.27%
- Remediation
- Version ranges on file
- Affected products
- cpe ekacnet/grafanacubism-panel · stated grafanacubism-panel
The grafanacubism-panel plugin allows use of cubism.js in Grafana. In 0.1.2 and earlier, the panel's zoom-link handler passes a dashboard-editor-supplied URL directly to window.location.assign() / window.open() with no scheme validation. An attacker with dashboard Editor privileges can set the link to a javascript: URI; when any Viewer drag-zooms on the panel, the payload executes in the Grafana origin.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- cpe ekacnet/grafanacubism-panelversion unspecified
- stated grafanacubism-panel<= 0.1.2
How to fix CVE-2026-32117
Recommended remediation
Affected version ranges suggest a fixed boundary. Verify against the vendor advisory for your release.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
No confirmed exploitation is on record for CVE-2026-32117. EPSS is 0.27%. Act only if a listed version of The grafanacubism-panel plugin allows is installed.
Which versions are affected?
Compare what you have installed with <= 0.1.2. Compare the installed version with the linked vendor advisory before you change production.
What should an analyst verify?
CWE-79: Cross-site Scripting (XSS). EPSS 0.27%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
Timeline
Detection, updates, and resolution for this record.
Mar 11, 2026 · NIST NVD
Detected
The grafanacubism-panel plugin allows use of cubism.js in Grafana. In 0.1.2 and earlier, the panel's zoom-link handler passes a dashboard-editor-supplied URL directly to window.location.assign() / window.open() with no scheme validation. An attacker with dashboard Editor privileges can set the link to a javascript: URI; when any Viewer drag-zooms on the panel, the payload executes in the Grafana o
Jun 17, 2026 · NIST NVD
Updated
The grafanacubism-panel plugin allows use of cubism.js in Grafana. In 0.1.2 and earlier, the panel's zoom-link handler passes a dashboard-editor-supplied URL directly to window.location.assign() / window.open() with no scheme validation. An attacker with dashboard Editor privileges can set the link to a javascript: URI; when any Viewer drag-zooms on the panel, the payload executes in the Grafana o
Sources
- CVE.orgVulnerability recordCVE-2026-32117
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2026-32117
30-day exploitation probability 0.3%
first.org - NIST NVDVulnerability recordCVE-2026-32117
The grafanacubism-panel plugin allows use of cubism.js in Grafana. In 0.1.2 and earlier, the panel's zoom-link handler passes a dashboard-editor-supplied URL directly to window.location.assign() / window.open() with no scheme validation. An attacker with dashboard Editor privileg
nvd.nist.gov
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.